Clinical trial
A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone…
NCT00369863 · Shahid Beheshti University of Medical Sciences, Other · Completed
Key facts
| NCT number | NCT00369863 |
|---|---|
| Title | A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema |
| Lead sponsor | Shahid Beheshti University of Medical Sciences, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Macular Edema |
| Intervention type | Drug |
| Interventions | Triamcinolone acetonide |
| Enrollment | 76 |
| Start date | Jun 1, 2002 |
| Completion | Jun 1, 2003 |
| First posted | Aug 30, 2006 |
| Last update posted | Feb 28, 2007 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: